-
3.82025 Impact Factor
-
3.52025 5 Year Impact Factor
-
41/141Infectious Diseases (Rank by Impact Factor)
-
5.92025 CiteScore
-
90/361Infectious Diseases (Rank by CiteScore)
Infectious Disease Management in Resource-Limited Settings
In 2025, OFID called for papers addressing the unique challenges and opportunities faced by health care systems in resource-limited environments when dealing with infectious diseases. Explore the resulting papers in this important new collection from the journal.
Read now
OFID Welcomes Editorial Mentee
The IDSA journals are pleased to announce the mentee participating in the 2026 editorial mentoring program. Nancy Aitcheson, MD, MSHP, from the Perelman School of Medicine at the University of Pennsylvania and the Centers for Disease Control and Prevention will be serving as OFID's editorial mentee. Dr. Aitcheson will work directly with OFID editors through January 2027 to gain a deeper understanding of a medical journal editor’s role and work. Our editors are grateful to all who applied and look forward to working with this year’s selected mentees.
Find out more
CID Is Now on Roon!
We’re excited to announce that Clinical Infectious Diseases now has an official presence on Roon, a physician-only social platform to advance knowledge-sharing in medicine.
Follow us for the latest updates, research highlights, and more from CID and the other IDSA journals, and respond to and discuss IDSA and other infectious diseases content with the Roon community.
Follow Clinical Infectious Diseases on Roon

OFID Now Offers Review Pathway for Papers Rejected by High-Impact Journals
Open Forum Infectious Diseases welcomes papers that have been peer reviewed by another medical journal and were not accepted for publication, where the authors believe they can address the essential concerns identified by previous reviewers. Under this new pathway, authors can revise the paper according to the review comments they previously received and then submit the paper to OFID. This new pathway is intended to speed publication and minimize unnecessary re-review of papers that previously received thorough and detailed review elsewhere.
Learn more about how to submit using this pathway.

JID for Clinicians
The Journal of Infectious Diseases has launched JID for Clinicians—a new initiative spotlighting research with relevance to clinical practice. The Editor-in-Chief provides a brief summary of key articles most useful to clinicians, making it easier than ever to stay informed and apply the latest evidence to patient care. Explore this new monthly roundup on the IDSA Science Speaks blog.
Read now
Background Leptospirosis is a climate-sensitive zoonosis with a high burden in tropical regions. During the 2020–2021 austral summer, New Caledonia experienced exceptionally heavy rainfall concurrent with one of its largest recorded outbreaks. Methods We conducted a retrospective observational ...
Background Leptospirosis is a climate-sensitive zoonosis with a high burden in tropical regions. During the 2020–2021 austral summer, New Caledonia experienced exceptionally heavy rainfall concurrent with one of its largest recorded outbreaks. Methods We conducted a retrospective observational ...
Among patients with newly diagnosed rifampin-resistant tuberculosis (RR-TB) and bedaquiline resistance (BDQ-R), 55% had no prior exposure to bedaquiline, suggesting primary transmission. Treatment outcomes in patients with BDQ-R RR-TB were poor, although better in patients with primary than acquired BDQ-R.





